ADC pipeline with multiple products entering key clinical stages Revenue increased by 350% year-on-year Focusing on the field of tumor…
Browsing: BioTech
In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies,…
– Sales of Innovative Products Up by 27.2% Year-on-Year to RMB7.8 Billion – Profit Attributable to Owners of the Parent…
Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults…
Everest Medicines (HKG: 1952.HK, Everest) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New…
Essex Bio-Technology Limited (Essex or the Group, HKG: 1061) is pleased to announce that a Biologics License Application (BLA) for…
Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical…
Everest Medicines (HKG: 1952) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R).…
Everest Medicines (HKG: 1952) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved…
Everest Medicines (HKG: 1952) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9…
Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media…
HONG KONG, July 25, 2025 – (ACN Newswire) – Essex Bio-Technology Limited (“Essex” or the “Group”, Stock Code: 1061.HK) is pleased…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies…
On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited (“CMS” or the “Group”)…
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF…
Everest Medicines (HKG: 1952) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held…
Technology Co-Developed by the U.S. Department of Veteran Affairs and Emory University Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the…
ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement in molecular diagnostic…
Hua Medicine (the Company, HKG: 2552) announced today that the Company presented the latest research results of dorzagliatin, its global…
Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to…